Align Technology (NASDAQ: ALGN) reported Q2 EPS of ($0.35), $0.31 worse than the analyst estimate of ($0.04). Revenue for the quarter came in at $352.3 million versus the consensus estimate of $322.62 million.

• Q2 Invisalign volume of 221.9 thousand cases, compared to 377.1 thousand cases in Q2’19
• Q2 Invisalign cases for teenage patients was 31.8% of total volumes at 70.6 thousand cases, compared to 27.5% of total volumes at 103.7 thousand cases in Q2’19
• Q2 Imaging Systems and CAD/CAM Services revenues of $54.0 million, compared to $104.0 million in Q2’19

GUIDANCE:

Due to the uncertain scope and duration of the pandemic, and uncertain timing of the global recovery and economic normalization, we cannot at this time reasonably estimate the future impact on our operations and financial results. Accordingly, we are not providing guidance for the third quarter of fiscal year 2020.

For earnings history and earnings-related data on Align Technology (ALGN) click here.